Skip to main content

Table 5 Hemodynamic variables before and during clonidine treatment

From: The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses

  

Baseline

Day 1, 3 h after dose 1

Day 1, 3 h after dose 2

Day 1, 3 h after dose 3

Day 1, 3 h after dose 4

Day 2, before morning dose

Last measurement during treatment

Delta 1a

Delta 2b

Clonidine

SBPc, mmHg

Median

141

138

130

133

128 d

135

137

−16

−10

 

Range

124–190

121–182

106–184

125–160

98 – 153d

81–170

102 – 238e

− 61 - 40

−46 - 98

DBPf, mmHg

Median

74

78

67

72

65d

78

75

−5

−9

 

Range

62–105

64–93

59–84

62–87

58–77d

49–97

56–109

−24 - 28

− 23 - 40

HRg, bpmh

Median

89

85

79

66

67d

84

76

− 6

−12

 

Range

71–106

64–92

63–101

62–92

60–894d

72–90

62–146

−41 - 18

− 32 - 61

Placebo

SBP, mmHg

Median

130

132

134

118

170i

140

136

7

8

 

Range

122–181

94–163

110–152

113–149

119–170

110–149

− 40 - 47

−56 - 19

DBP, mmHg

Median

72

76

72

70

85i

77

62

5

1

 

Range

54–105

58–103

56–105

56–85

61–103

58–96

−27 - 19

−31 - 22

HR, bpm

Median

87

85

84

75

75i

84

80

1

1

 

Range

53–123

58–105

64–106

58–88

65–140

64–130

−34 - 30

−36 - 36

  1. Bold characters mark time points with a significant change in value from baseline (for SBP at 3 h after dose 2 and 4 (respectively p = 0.047 and p = 0.043), for DBP 3 h after dose 2 (p = 0.047) and for HR 3 h after dose 3 (p = 0.028)). The within group differences were otherwise not statistically significant
  2. abaseline to day 2, before morning dose
  3. bfrom baseline to last measurement during treatment
  4. cSBP = systolic blood pressure
  5. dMeasurements from 5 of 7 patients that received the 4th loading dose
  6. eOne patient had SBP 238 mmHg at the last measurement during treatment, as a part of a hypertensive pulmonary oedema
  7. fDBP = diastolic blood pressure
  8. gHR = heart rate
  9. hbpm = beats per minute
  10. iMeasurements only from one patient